Autoimmune autonomic ganglionopathy
| Autoimmune autonomic ganglionopathy | |
|---|---|
| Synonyms | AAG |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Severe orthostatic hypotension, anhidrosis, constipation, urinary retention, dry mouth, dry eyes |
| Complications | N/A |
| Onset | Typically acute or subacute |
| Duration | Can be chronic |
| Types | N/A |
| Causes | Autoimmune disease targeting nicotinic acetylcholine receptors in autonomic ganglia |
| Risks | Genetic predisposition, viral infection |
| Diagnosis | Clinical evaluation, serological testing for ganglionic acetylcholine receptor antibodies |
| Differential diagnosis | Multiple system atrophy, pure autonomic failure, Guillain-Barré syndrome |
| Prevention | N/A |
| Treatment | Immunotherapy (e.g., IVIG, plasmapheresis, corticosteroids), symptomatic treatment |
| Medication | N/A |
| Prognosis | Variable; some patients improve with treatment, others may have persistent symptoms |
| Frequency | Rare |
| Deaths | N/A |
A rare autoimmune disorder affecting the autonomic nervous system
Autoimmune autonomic ganglionopathy (AAG) is a rare disorder characterized by the immune system mistakenly attacking the autonomic ganglia, which are clusters of nerve cells that regulate the autonomic nervous system (ANS). The ANS controls involuntary bodily functions such as heart rate, blood pressure, digestion, and temperature regulation.
Pathophysiology[edit]
The pathophysiology of AAG involves the production of autoantibodies that target the nicotinic acetylcholine receptors (nAChRs) located in the autonomic ganglia. These receptors are crucial for the transmission of nerve signals within the ANS. The binding of autoantibodies to these receptors disrupts normal autonomic function, leading to a wide range of symptoms.
Symptoms[edit]
The symptoms of AAG can vary widely depending on the extent and location of autonomic dysfunction. Common symptoms include:
- Severe orthostatic hypotension, leading to dizziness or fainting upon standing
- Gastrointestinal dysmotility, resulting in nausea, vomiting, constipation, or diarrhea
- Anhidrosis or hyperhidrosis, affecting the body's ability to regulate temperature
- Urinary retention or incontinence
- Pupillary abnormalities, such as fixed or dilated pupils
- Dry mouth and dry eyes
Diagnosis[edit]
Diagnosing AAG involves a combination of clinical evaluation, laboratory tests, and autonomic function tests. Key diagnostic steps include:
- Clinical evaluation: A thorough history and physical examination to assess symptoms and rule out other conditions.
- Serological tests: Detection of ganglionic acetylcholine receptor antibodies in the blood, which are present in many cases of AAG.
- Autonomic function tests: These may include tilt table testing, quantitative sudomotor axon reflex test (QSART), and heart rate variability analysis to assess autonomic function.
Treatment[edit]
Treatment of AAG focuses on managing symptoms and modulating the immune response. Options include:
- Immunotherapy: Such as intravenous immunoglobulin (IVIG), plasmapheresis, or immunosuppressive drugs like corticosteroids, azathioprine, or rituximab.
- Symptomatic treatment: Medications to manage specific symptoms, such as fludrocortisone or midodrine for orthostatic hypotension, and prokinetic agents for gastrointestinal symptoms.
Prognosis[edit]
The prognosis of AAG varies. Some patients may experience significant improvement with treatment, while others may have persistent symptoms. Early diagnosis and treatment are crucial for better outcomes.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian